Vitamin D Supplementation: A Potential Approach for Coronavirus/COVID-19 Therapeutics?

Front Immunol. 2020 Jun 23:11:1523. doi: 10.3389/fimmu.2020.01523. eCollection 2020.
No abstract available

Keywords: COVID-19; SARS-Cov-2; anti-inflammatory; antiviral; vitamin D.

MeSH terms

  • Angiotensin-Converting Enzyme 2
  • Betacoronavirus*
  • COVID-19
  • COVID-19 Drug Treatment
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / virology
  • Dietary Supplements
  • Host-Pathogen Interactions / drug effects
  • Humans
  • Pandemics
  • Peptidyl-Dipeptidase A / metabolism
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / epidemiology*
  • Pneumonia, Viral / virology
  • Protective Agents / administration & dosage
  • Protective Agents / pharmacology
  • Protective Agents / therapeutic use*
  • Renin-Angiotensin System / drug effects
  • SARS-CoV-2
  • Signal Transduction / drug effects
  • Spike Glycoprotein, Coronavirus / metabolism
  • Vitamin D / administration & dosage
  • Vitamin D / pharmacology
  • Vitamin D / therapeutic use*
  • Vitamins / administration & dosage
  • Vitamins / pharmacology
  • Vitamins / therapeutic use*

Substances

  • Protective Agents
  • Spike Glycoprotein, Coronavirus
  • Vitamins
  • spike protein, SARS-CoV-2
  • Vitamin D
  • Peptidyl-Dipeptidase A
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2